Press Room

Share

Nomination of Dr. Francis Collins as NIH Director Good for Cancer Research

July 9, 2009

WASHINGTON, D.C. -- July 9, 2009 -- “The cancer community applauds President Obama’s nomination of Dr. Francis Collins as the Director of the National Institutes of Health (NIH). In this role, Dr. Collins would bring his scientific leadership and experience to one of the nation’s foremost medical and cancer research facilities. His background as an administrator at the NIH, especially his role in leading the Human Genome Project, gives him a rich and unique perspective that would be an asset in the job.

“This is a critical time for the NIH, which endured five straight years of frozen or cut funding before receiving a boost in funding earlier this year. We must continue to make the necessary investment in medical research to produce scientific discoveries that will continue our progress against cancer and other life-threatening diseases. With Dr. Collins as its leader, I am confident that the NIH will be in good hands and that we will continue to save more lives and create a world with more birthdays.”

ACS CAN, the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society, supports evidence-based policy and legislative solutions designed to eliminate cancer as a major health problem. ACS CAN works to encourage elected officials and candidates to make cancer a top national priority. ACS CAN gives ordinary people extraordinary power to fight cancer with the training and tools they need to make their voices heard. For more information, visit https://www.fightcancer.org/.

FOR MORE INFORMATION, CONTACT:
Alissa Havens
Phone: (202) 661-5772
Email: [email protected]

Christina Saull
Phone: (202) 585-3250
Email: [email protected]

More Press Releases AboutCancer Research Funding

Related Press Releases

March 21, 2024

Congress Considers FY24 Appropriations Bill That Prioritizes Cancer Research and Proven Cancer Screening Funding Amidst Difficult Budget Cycle

WASHINGTON, D.C.— March 21, 2024 — Today, Congress released a series of spending bills aimed to finalize FY2024 funding that includes a $300 million increase in funding for the National Health Institute (NIH) base budget, including a $120 million increase in discretionary funding for the National Cancer Institute (NCI), a modest $500,000 increase for the Centers for Disease Control and Prevention (CDC) cancer screening and prevention programs and maintains the current funding level for the Advanced Research Projects Agency for Health (ARPA-H) at $1.5 billion. At NIH, the bill also includes a first-time appropriation of $12.5 million in dedicated funding for the development of palliative care research at NIH and a new $6 million initiative for Improving Native American Cancer Outcomes. Within the Department of Defense (DoD), the bill includes a $110 million for the Prostate Cancer Research Program. 

Read More
March 24, 2023

New Jersey is taking a giant leap forward in the war against cancer. Here's how

The following originally appeared in the Asbury Park Press on March 24, 2023.

 

Read more
March 11, 2024

President’s FY25 Budget Prioritizes Funding for Cancer Research and Prevention

The American Cancer Society Cancer Action Network (ACS CAN) is pleased to see President Biden’s continued focus on and dedication to achieving the goal of the Cancer Moonshot to end cancer as we know it, for everyone.

Read more